Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$6.23 - $10.03 $46,725 - $75,225
-7,500 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$8.5 - $12.85 $59,789 - $90,386
7,034 Added 1509.44%
7,500 $66,000
Q3 2020

Oct 28, 2020

BUY
$9.57 - $27.05 $1,588 - $4,490
166 Added 55.33%
466 $5,000
Q2 2020

Jul 20, 2020

BUY
$7.14 - $31.69 $2,142 - $9,507
300 New
300 $8,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $461M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.